Table 2.
Blood parameters, platelet size, glycoprotein expression, and annexin V and tissue factor binding in patients 1 and 2, their mothers, and control subjects
| P1 | P2 | Mother of P1 | Mother of P2 | Control 1 | Control 2 | |
|---|---|---|---|---|---|---|
| WBC (×109/L) | 16.1 | 8.2 | 5.2 | 8.6 | 7.2 | 7.8 |
| Hb (g/dl) | 13.9 | 12.7 | 12.4 | 13.5 | 12.8 | 14.3 |
| Ht (%) | 40.2 | 37.9 | 36.6 | 39.9 | 37.7 | 42.6 |
| Platelets (×109/L) | 24 | 7 | 213 | 226 | 207 | 206 |
| FSC (MFI) | 32.9 | 32.9 | 26.8 | 27.9 | 25.7 | 25.6 |
| CD42b (MFI) | 127.2 | 122.8 | 152.7 | 186.2 | 161.3 | 199.5 |
| CD42a (MFI) | 187.2 | 189.2 | 188.1 | 207.7 | 180.6 | 212.8 |
| CD61 (MFI) | 209.8 | 215.3 | 194.5 | 237.8 | 216.7 | 226.4 |
| CD49b (MFI) | 29.5 | 28.5 | 33.6 | 41.1 | 39.5 | 31.6 |
| Annexin V (% positive) | 2.5 | 1.7 | 5.9 | 4.2 | 4.7 | 3.6 |
| Tissue factor (% positive) | 4.2 | 4.4 | 7.8 | 5.9 | 7.5 | 6.2 |
Abbreviations: FSC, forward side scatter; Hb, hemoglobin; Ht, hematocrit; MFI, median fluorescence intensity; P1, patient 1; P2, patient 2; WBC, white blood cells.